Form 4 for KYMR Kymera Therapeutics, Inc.
Accepted 2021-08-02 00:00:00 ET · period of report 2021-07-29 · accession 0001209191-21-049110 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-08-02 | 2021-07-29+ | KYMR | Mainolfi Nello | CEO, Dir | S - Sale+OE | $60.25 | -30.4K | 452.2K | -6% | -$1.83M |
| DM | 2021-08-02 | 2021-07-29+ | KYMR | Mainolfi Nello | CEO, Dir | M - OptEx | $2.08 | +30.4K | 475.7K | +7% | +$63.3K |
| DM | 2021-08-02 | 2021-07-29+ | KYMR | Mainolfi Nello | CEO, Dir | M - OptEx | $0.00 | -30.4K | 106.9K | -22% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-07-29 | S | D | 680 | $60.00 | 452,199 | D | — | — | |
| 2 | Common | Common Stock | 2021-08-02 | S | D | 1,524 | $61.28 | 452,499 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $61.00 to $61.98. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 3 | Common | Common Stock | 2021-08-02 | S | D | 21,632 | $60.21 | 454,023 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $60.00 to $60.86. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 4 | Common | Common Stock | 2021-08-02 | S | D | 300 | $62.21 | 452,199 | D | — | — | (F5) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $62.205 to $62.21. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 5 | Common | Common Stock | 2021-07-30 | S | D | 6,279 | $60.07 | 452,199 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $60.00 to $60.26. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 6 | Common | Common Stock | 2021-07-30 | M | A | 6,279 | $2.08 | 458,478 | D | — | — | |
| 7 | Common | Common Stock | 2021-07-29 | M | A | 680 | $2.08 | 452,879 | D | — | — | |
| 8 | Common | Common Stock | 2021-08-02 | M | A | 23,456 | $2.08 | 475,655 | D | — | — | |
| 9 | Derivative | Stock Option (Right to Buy) | 2021-08-02 | M | D | 23,456 | $0.00 | 83,431 | D | $2.08 · — to 2029-11-13 | 23,456 Common Stock | (F6) The shares underlying this stock option shall vest upon the achievement of specified performance-based milestones. |
| 10 | Derivative | Stock Option (Right to Buy) | 2021-07-29 | M | D | 680 | $0.00 | 113,166 | D | $2.08 · — to 2029-11-13 | 680 Common Stock | (F6) The shares underlying this stock option shall vest upon the achievement of specified performance-based milestones. |
| 11 | Derivative | Stock Option (Right to Buy) | 2021-07-30 | M | D | 6,279 | $0.00 | 106,887 | D | $2.08 · — to 2029-11-13 | 6,279 Common Stock | (F6) The shares underlying this stock option shall vest upon the achievement of specified performance-based milestones. |